Home›Stock Screener›Curis Lifesciences

Curis Lifesciences Share Price Today | Stock Price & Curis Lifesciences Share Screener

CURIS Pharmaceuticals

Track the current Curis Lifesciences share price and stock price live with TickJournal's free stock screener. Check CURIS annual price range for the annual price range and momentum. Use the Curis Lifesciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Curis Lifesciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹9 and net income of ₹1, with EBITDA of ₹3, an operating margin of 30.0% and a profit margin of 11.1%.

Curis Lifesciences Market Cap ₹175.67 Cr.
CURIS P/E Ratio (TTM) 33.94
Curis Lifesciences P/B Ratio 4.86
EPS (TTM) ₹37.14
Dividend Yield -
Debt to Equity 0.58
CURIS 52 Week High -
Curis Lifesciences 52 Week Low -
Operating Margin 30.00%
Profit Margin 11.11%
CURIS Revenue (TTM) ₹9.00
EBITDA ₹3.00
Net Income ₹1.00
Total Assets ₹82.00
Total Equity ₹47.00

Curis Lifesciences Share Price Chart

Track the current stock price of Curis Lifesciences with an interactive chart. Analyse CURIS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Curis Lifesciences stock quote in one place.

Curis Lifesciences Company Profile - Fundamental Screener

Screen Curis Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CURIS shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE1BZN01016.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE1BZN01016

Curis Lifesciences Balance Sheet Screener

Screen CURIS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹82, up from ₹43 in 2025.

Latest statistics put total assets at ₹82 and shareholder funds at ₹47, with a leverage ratio of 0.58.

Item 2026 2025 2024 2023 2022

Assets

Total Assets 82 43 34 30 27
Current Assets 69 31 22 17 15
Fixed Assets 11 11 12 12 12

Liabilities

Total Liabilities 0 0 0 0 0
Current Liabilities 7 9 10 10 13
Non-Current Liabilities 0 0 0 0 0

Shareholders' Equity

Total Equity 47 17 6 0 -1
Share Capital 8 6 1 1 1
Reserves & Surplus 39 11 5 0 -1

Curis Lifesciences Income Statement Screener - Profit & Revenue Analysis

Screen Curis Lifesciences income statement and profit fundamentals. Analyze CURIS quarterly results. Curis Lifesciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2024-Jun, revenue was ₹9 and net profit was ₹1, equal to earnings per unit of ₹24.00, at an operating margin of 30%.

Item 2024-Jun

Revenue and Expenses

Revenue 9
Expenses 6

Operating Costs and Margins

EBITDA 3
Operating Profit % 30.00%
Depreciation 0
Interest 0

Profit and Earnings

Profit Before Tax 2
Tax 1
Net Profit 1
EPS 24.00

Curis Lifesciences Cash Flow Screener - Liquidity Fundamentals

Screen CURIS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹16, and net cash flow was an inflow of ₹3.

Over the same period, investing activities used ₹2 and financing activities provided ₹21.

Item 2026-March 2025-March 2024-March 2023-March 2022-March

Cash from Operations and Investing

Operating Activities -16 -2 0 3 5
Investing Activities -2 0 0 -1 0

Financing and Net Cash

Financing Activities 21 2 0 -3 -5
Net Cash Flow 3 0 0 0 0

Curis Lifesciences Shareholding Pattern Screener

See Curis Lifesciences shareholding pattern with promoter, FII, and DII holdings. Check Curis Lifesciences promoter holding and ownership changes for CURIS on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 68.03%, foreign institutions 1.19%, domestic institutions 5.80% and the public 14.38%, spread across 340 shareholders.

The shareholder count was 340 in 2026-Mar, compared with 35 in 2025-Jun.

Item 2026-Mar 2025-Jun 2025-Oct 2025-Nov 2024-Dec

Promoter Holding

Promoter Holding 68.03% 92.68% 92.68% 68.03% 92.68%

Institutional Investors

FII Holding 1.19% 0.00% 0.00% 2.93% 0.00%
DII Holding 5.80% 0.00% 0.00% 10.86% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 14.38% 0.00% 0.00% 13.97% 4.37%
Other Holding 10.60% 7.32% 7.32% 4.20% 2.95%
Shareholder Count 340 35 36 36 27

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Curis Lifesciences. Curis Lifesciences dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Curis Lifesciences.

Curis Lifesciences Stock Index Membership - Nifty & Sensex

See which indices include Curis Lifesciences stock. Check CURIS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Curis Lifesciences is not part of any tracked indices.
Only major market indices are tracked in our system.

Curis Lifesciences Market Events Screener - Corporate Actions

Get Curis Lifesciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Curis Lifesciences stock events that may affect CURIS share price, along with derivatives, futures and options activity and sector gainers.

2 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated May 30, 2026, with a record date of May 30, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-05-30 2026-05-30 Quarterly Result Announcement NA -3.28%
2025-12-04 2025-12-04 Quarterly Result Announcement NA -9.29%

Curis Lifesciences Competitors Screener - Peer Stocks Comparison

Screen CURIS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 435,863 36.83 61,674 12.69% 11,565 38.95
Divis Laboratories 246,660 86.00 11,067 13.95% 2,568 53.27
Torrent Pharmaceuticals 182,577 86.72 13,886 20.34% 2,138 42.82
Zydus Life Science 115,910 25.96 27,658 17.64% 5,026 51.33
Cipla 108,738 33.29 29,045 2.24% 3,870 35.23
Laurus Labs 106,982 98.39 6,868 22.01% 890 58.13
Mankind Pharma 103,418 50.84 14,636 14.85% 1,938 59.40
Dr Reddys Laboratories 102,916 32.77 35,059 3.90% 4,158 62.37
Aurobindo Pharma 96,203 26.41 34,145 5.56% 3,503 49.32
Lupin 92,839 16.97 29,039 26.75% 5,356 31.32

Curis Lifesciences Company Announcements - News & Reports Screener

Screen CURIS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

No company announcements available.

Frequently Asked Questions

How is the company valued right now?

The P/E ratio is 33.94 and the P/B ratio is 4.86, with earnings per unit of ₹37.14. Market capitalisation stands at ₹175.67 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on October 6, 2026. This page covers 5 balance sheet periods, 1 income statement periods, 5 cash flow years and 5 shareholding periods. Information is provided for research and is not investment advice.